Amersham Biosciences Appoints Dr. Trevor Hawkins Senior Vice President of Genomics.Business Editors & Health/Medical Writers BIOWIRE2K PISCATAWAY, N.J.--(BW HealthWire)--Feb. 15, 2002 Amersham Biosciences, the life sciences business of Amersham plc (LSE LSE - Language Sensitive Editor :, NYSE NYSE See: New York Stock Exchange :, OSE OSE - Open Systems Environment : AHM AHM Automated Hacking Machines AHM All Hands Meeting AHM Academy for Healthcare Management AHM Atom Heart Mother (Pink Floyd album) AHM Airport Handling Manual AHM Acutely Hazardous Material AHM Anti-Helicopter Mine ), today announced the appointment of Dr. Trevor Hawkins as Senior Vice President of Genomics. Dr. Hawkins will be responsible for setting the strategic direction of the company's genomics business and for building it into a strong and profitable business area. He will report to Andrew Carr, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Amersham Biosciences, and will join the company's executive committee. The position will initially be based in Sunnyvale, California. Dr. Hawkins joins Amersham Biosciences from his position as Director of the Department of Energy's Joint Genome Institute The DOE Joint Genome Institute (JGI) was created in 1997 to unite the expertise and resources in genome mapping, DNA sequencing, technology development, and information sciences pioneered at the DOE genome centers at Lawrence Berkeley National Laboratory (LBNL), Lawrence Livermore (JGI JGI Joint Genome Institute JGI Jane Goodall Institute JGI Just Got It (chat) JGI Just Google It ), which is internationally recognized as one of the world's leading sequencing centers and for its role in the Human Genome Project. Dr. Hawkins started his career with the JGI in 1999 as Deputy Director, was appointed Lawrence Berkeley National Laboratory Lawrence Berkeley National Laboratory and Lawrence Livermore National Laboratory, scientific research centers run by the Univ. of California, located in Berkeley, Calif., and Livermore, Calif., respectively. Genomics Division Director in July 2000 and became Director of the JGI in November 2000. Prior to joining the JGI, he served as Vice President of Genomics for CuraGen Corporation. Dr. Hawkins obtained his B.Sc at the University of Sussex in the United Kingdom and completed a Ph.D. in biochemistry in 1993. "Through his numerous contributions in the field of genomics, Trevor Hawkins has established himself as a leader in the industry, and we are delighted to welcome him to our senior management team," said Andrew Carr, CEO, Amersham Biosciences. "With his proven ability to build and lead complex teams and projects, combined with his first hand experience of customer needs, Trevor will be an asset in helping the company to realize the value of the considerable investments we have made and will continue to make in the field of genomics." Amersham Biosciences, the life sciences business of Amersham plc (LSE: NYSE: OSE: AHM), is a world leader in developing and providing integrated systems and solutions for disease research, drug development and manufacture. Our systems are used to uncover the function of genes and proteins, for the discovery and development of drugs and for the manufacture of biopharmaceuticals. The customers for Amersham Biosciences' products and technology are pharmaceutical and biotechnology companies and research and academic institutions, principally in North America, Europe, Latin America and Asia. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion